Related Experiment Video
Updated: Dec 3, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Understanding rare infections post-lung transplantation
Lorena van den Bogaart1,2, Ana Cipriano3, Angela Koutsokera4
1Infectious Diseases Service, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Lung transplant recipients face high infectious risks. This review covers rare infections, emphasizing molecular diagnostics and multidisciplinary teams for timely management of viral, fungal, bacterial, and parasitic diseases.
Area of Science:
- Transplant Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Lung transplant recipients (LTRs) exhibit the highest susceptibility to infections among solid-organ transplant (SOT) recipients.
- Standardized protocols have improved management of common infections in LTRs.
- Rare infections pose diagnostic challenges, potentially delaying critical treatment.
Purpose of the Study:
- To review the epidemiology, clinical presentation, and diagnostic/therapeutic strategies for rare infections in LTRs.
- To highlight the importance of recognizing and managing uncommon infectious agents in this vulnerable population.
Main Methods:
- Literature review focusing on viral, fungal, bacterial, and parasitic infections in LTRs.
- Discussion of diagnostic approaches, including molecular methods like PCR.
- Emphasis on multidisciplinary team collaboration.
Main Results:
- Rare infections in LTRs require specific diagnostic considerations beyond common pathogens.
- Molecular diagnostic tools, such as PCR, are crucial for identifying rare infections.
- Prompt diagnosis and treatment are facilitated by a coordinated, multidisciplinary approach.
Conclusions:
- Clinical suspicion, supported by advanced molecular diagnostics, is key to diagnosing rare infections in LTRs after common causes are excluded.
- A collaborative team of transplant pulmonologists, infectious disease specialists, microbiologists, and pathologists is essential for optimal patient outcomes.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant III: Nursing Management
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

